Labeling for Human Prescription Drug/Biologic Products | Federal Regulations · Congress.wiki

Rulemaking

FDA

RIN 0910-AA94

FDA-2000-N-0044

Labeling for Human Prescription Drug/Biologic Products

Documents

Comments

Description

CLOSED DATE: 01/24/2006 Docket Status: CLOSED

Comment Period OpensDec 27, 2000

Comment Period ClosesJun 23, 2001

Type	Title	Posted	Comments	Status
Other	HF-40 to Arizona Osteopathic Medical Association (AOMA)	Jul 29, 2008	--

FORMAT/CONTENT

REDUCE MEDICATION ERRORS

ADVERSE REACTIONS

OVERDOSAGE

DRUG ABUSE/DEPENDENCE

BIOLOGICS PRODUCTS

CLINICAL MICROBIOLOGY

HUMN PRESCRIPTION DRUG

LABELING